124 related articles for article (PubMed ID: 9815609)
21. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Müller V; Jensen EV; Knabbe C
Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
[TBL] [Abstract][Full Text] [Related]
22. Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780.
Huynh H; Nickerson T; Pollak M; Yang X
Clin Cancer Res; 1996 Dec; 2(12):2037-42. PubMed ID: 9816164
[TBL] [Abstract][Full Text] [Related]
23. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
24. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells.
Rajah TT; Dunn ST; Pento JT
Anticancer Res; 1996; 16(2):837-42. PubMed ID: 8687138
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer growth inhibition by delivery of the MDGI-derived peptide P108.
Wang HL; Kurtz A
Oncogene; 2000 May; 19(20):2455-60. PubMed ID: 10828888
[TBL] [Abstract][Full Text] [Related]
26. Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens.
Murphy LC; Dotzlaw H
Cancer Res; 1989 Feb; 49(3):599-604. PubMed ID: 2783382
[TBL] [Abstract][Full Text] [Related]
27. Estradiol induction of retinoic acid receptors in human breast cancer cells.
Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
[TBL] [Abstract][Full Text] [Related]
28. Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus.
Zierau O; O'Sullivan J; Morrissey C; McDonald D; Wünsche W; Schneider MR; Tenniswood MP; Vollmer G
Endocr Relat Cancer; 2004 Dec; 11(4):823-30. PubMed ID: 15613455
[TBL] [Abstract][Full Text] [Related]
29. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Osborne CK; Boldt DH; Estrada P
Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
[TBL] [Abstract][Full Text] [Related]
30. Induction of mammary epithelial cell differentiation and inhibition of dimethylbenz(A)anthracene-induced mammary tumour by co-administration of a pure antiestrogen ICI 182,780 and testosterone enanthate.
Chan TW; Mark G; Huynh H
Int J Oncol; 2001 Aug; 19(2):263-9. PubMed ID: 11445837
[TBL] [Abstract][Full Text] [Related]
31. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
32. Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.
Roberts CG; Millar EK; O'Toole SA; McNeil CM; Lehrbach GM; Pinese M; Tobelmann P; McCloy RA; Musgrove EA; Sutherland RL; Butt AJ
Oncogene; 2011 Jul; 30(28):3186-97. PubMed ID: 21383694
[TBL] [Abstract][Full Text] [Related]
33. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
Lim YC; Desta Z; Flockhart DA; Skaar TC
Cancer Chemother Pharmacol; 2005 May; 55(5):471-8. PubMed ID: 15685451
[TBL] [Abstract][Full Text] [Related]
34. Regulation of parathyroid hormone-related protein expression in MCF-7 breast carcinoma cells by estrogen and antiestrogens.
Funk JL; Wei H
Biochem Biophys Res Commun; 1998 Oct; 251(3):849-54. PubMed ID: 9790998
[TBL] [Abstract][Full Text] [Related]
35. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media.
Pratt SE; Pollak MN
Cancer Res; 1993 Nov; 53(21):5193-8. PubMed ID: 7693333
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
37. Developmental regulation of mammary-derived growth inhibitor expression in bovine mammary tissue.
Kurtz A; Vogel F; Funa K; Heldin CH; Grosse R
J Cell Biol; 1990 May; 110(5):1779-89. PubMed ID: 2335570
[TBL] [Abstract][Full Text] [Related]
38. Irregular distribution of mammary-derived growth inhibitor in the bovine mammary epithelium.
Erdmann B; Breter H
Cell Tissue Res; 1993 May; 272(2):383-9. PubMed ID: 8513489
[TBL] [Abstract][Full Text] [Related]
39. Members of the fatty acid binding protein family are differentiation factors for the mammary gland.
Yang Y; Spitzer E; Kenney N; Zschiesche W; Li M; Kromminga A; Müller T; Spener F; Lezius A; Veerkamp JH
J Cell Biol; 1994 Nov; 127(4):1097-109. PubMed ID: 7962070
[TBL] [Abstract][Full Text] [Related]
40. Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocyte-type fatty acid-binding protein.
Specht B; Bartetzko N; Hohoff C; Kuhl H; Franke R; Börchers T; Spener F
J Biol Chem; 1996 Aug; 271(33):19943-9. PubMed ID: 8702709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
